Kanmani Bharathi

Dr. Kanmani Bharathi

Molecular Biology and Biotechnology, Annamalai University, Chidambaram, India
orcid
Research Consultant

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2022 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
Kanmani BharathiKanmani Bharathi
Kanmani Bharathi
RARamaswamy Anandan
Ramaswamy Anandan
LBLincy Kirubhadharsini Benjamin
Lincy Kirubhadharsini Benjamin
Sowbiya MuneerSowbiya Muneer
Sowbiya Muneer
PSPrakash SM
Prakash SM

7 September 2024 in Heliyon
Verified
Journal Article
Open access
Kanmani BharathiKanmani Bharathi
Kanmani Bharathi
PSPreethika Suresh
Preethika Suresh
PSPrakash SM
Prakash SM
Sowbiya MuneerSowbiya Muneer
Sowbiya Muneer
An excellent technique for producing pharmaceuticals called "molecular farming" enables the industrial mass production of useful recombinant proteins in genetically modified organisms. Protein-based pharmaceuticals are rising in significance because of a variety of factors, including their bioreactivity, precision, safety, and efficacy rate. Heterologous expression methods for the manufacturing of pharmaceutical products have been previously employed using yeast, bacteria, and animal cells. However, the high cost of mammalian cell system, and production, the chance for product complexity, and contamination, and the hurdles of scaling up to commercial production are the limitations of these traditional expression methods. Plants have been raised as a hopeful replacement system for the expression of biopharmaceutical products due to their potential benefits, which include low production costs, simplicity in scaling up to commercial manufacturing levels, and a lower threat of mammalian toxin contaminations and virus infections. Since plants are widely utilized as a source of therapeutic chemicals, molecular farming offers a unique way to produce molecular medicines such as recombinant antibodies, enzymes, growth factors, plasma proteins, and vaccines whose molecular basis for use in therapy is well established. Biopharming provides more economical and extensive pharmaceutical drug supplies, including vaccines for contagious diseases and pharmaceutical proteins for the treatment of conditions like heart disease and cancer. To assess its technical viability and the efficacy resulting from the adoption of molecular farming products, the following review explores the various methods and methodologies that are currently employed to create commercially valuable molecules in plant systems.

9 August 2025 in Water, Air, & Soil Pollution
Verified
Journal Article
Closed access
Kanmani BharathiKanmani Bharathi
Kanmani Bharathi
MPMuthu Arjuna Samy Prakash
Muthu Arjuna Samy Prakash

25 June 2022 in South African Journal of Botany
Verified
Journal Article
Open access
Kanmani BharathiKanmani Bharathi
Kanmani Bharathi
RARamaswamy Anandan
Ramaswamy Anandan
SRSrinivasan Rameshkumar
Srinivasan Rameshkumar
KMKannan Menaka
Kannan Menaka
MPMuthu Arjuna Samy Prakash
Muthu Arjuna Samy Prakash


30 November 2023 in Brazilian Journal of Botany
Verified
Journal Article
Closed access
PDF file
BPB. Priyadharshini
B. Priyadharshini
RAR. Anandan
R. Anandan
SMS. Manikandan
S. Manikandan
Kanmani BharathiKanmani Bharathi
Kanmani Bharathi
PSPrakash SM
Prakash SM